APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dutasteride

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dutasteride Market Analysis and Forecast 2026-2032

20 December 2025199 pages

Choose your research edition.

Industry ResearchDutasteride Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Dutasteride Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Dutasteride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dutasteride Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Dutasteride Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Dutasteride market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dutasteride is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dutasteride is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dutasteride is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dutasteride is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dutasteride include GSK, Amneal Pharma, Apotex, Bionpharma, Breckenridge Pharmaceutical, Marksans Pharma, Rising Pharmaceuticals, Zydus and Mylan, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dutasteride, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dutasteride, also provides the sales of main regions and countries. Of the upcoming market potential for Dutasteride, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dutasteride sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dutasteride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dutasteride sales, projected growth trends, production technology, application and end-user industry.

Dutasteride Segment by Company

GSK

Amneal Pharma

Apotex

Bionpharma

Breckenridge Pharmaceutical

Marksans Pharma

Rising Pharmaceuticals

Zydus

Mylan

Teva

Dutasteride Segment by Type

Type I

Type II

Dutasteride Segment by Application

Hospital

Drug Store

Dutasteride Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dutasteride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dutasteride and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dutasteride.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dutasteride in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dutasteride manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dutasteride sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dutasteride Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Type I Major Manufacturers Table 3. Type II Major Manufacturers Table 4. Global Dutasteride Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Drug Store Major Manufacturers Table 7. Dutasteride Industry Trends Table 8. Dutasteride Industry Drivers Table 9. Dutasteride Industry Opportunities and Challenges Table 10. Dutasteride Industry Restraints Table 11. Global Dutasteride Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Dutasteride Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Dutasteride Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Dutasteride Revenue Market Share by Region (2021-2026) Table 15. Global Dutasteride Revenue Market Share by Region (2027-2032) Table 16. Global Dutasteride Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 17. Global Dutasteride Sales by Region (2021-2026) & (W Units) Table 18. Global Dutasteride Sales by Region (2027-2032) & (W Units) Table 19. Global Dutasteride Sales Market Share by Region (2021-2026) Table 20. Global Dutasteride Sales Market Share by Region (2027-2032) Table 21. Global Dutasteride Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Dutasteride Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Dutasteride Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Dutasteride Sales Market Share by Manufacturers (2021-2026) Table 25. Global Dutasteride Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Dutasteride Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Dutasteride Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Dutasteride Manufacturers, Product Type & Application Table 29. Global Dutasteride Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Dutasteride by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Dutasteride Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Dutasteride Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Dutasteride Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Dutasteride Revenue Market Share by Type (2021-2026) Table 36. Global Dutasteride Revenue Market Share by Type (2027-2032) Table 37. Global Dutasteride Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 38. Global Dutasteride Sales by Type (2021-2026) & (W Units) Table 39. Global Dutasteride Sales by Type (2027-2032) & (W Units) Table 40. Global Dutasteride Sales Market Share by Type (2021-2026) Table 41. Global Dutasteride Sales Market Share by Type (2027-2032) Table 42. Global Dutasteride Price by Type (2021-2026) & (US$/Unit) Table 43. Global Dutasteride Price by Type (2027-2032) & (US$/Unit) Table 44. Global Dutasteride Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Dutasteride Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Dutasteride Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Dutasteride Revenue Market Share by Application (2021-2026) Table 48. Global Dutasteride Revenue Market Share by Application (2027-2032) Table 49. Global Dutasteride Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 50. Global Dutasteride Sales by Application (2021-2026) & (W Units) Table 51. Global Dutasteride Sales by Application (2027-2032) & (W Units) Table 52. Global Dutasteride Sales Market Share by Application (2021-2026) Table 53. Global Dutasteride Sales Market Share by Application (2027-2032) Table 54. Global Dutasteride Price by Application (2021-2026) & (US$/Unit) Table 55. Global Dutasteride Price by Application (2027-2032) & (US$/Unit) Table 56. GSK Company Information Table 57. GSK Business Overview Table 58. GSK Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. GSK Dutasteride Product Portfolio Table 60. GSK Recent Development Table 61. Amneal Pharma Company Information Table 62. Amneal Pharma Business Overview Table 63. Amneal Pharma Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Amneal Pharma Dutasteride Product Portfolio Table 65. Amneal Pharma Recent Development Table 66. Apotex Company Information Table 67. Apotex Business Overview Table 68. Apotex Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Apotex Dutasteride Product Portfolio Table 70. Apotex Recent Development Table 71. Bionpharma Company Information Table 72. Bionpharma Business Overview Table 73. Bionpharma Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bionpharma Dutasteride Product Portfolio Table 75. Bionpharma Recent Development Table 76. Breckenridge Pharmaceutical Company Information Table 77. Breckenridge Pharmaceutical Business Overview Table 78. Breckenridge Pharmaceutical Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Breckenridge Pharmaceutical Dutasteride Product Portfolio Table 80. Breckenridge Pharmaceutical Recent Development Table 81. Marksans Pharma Company Information Table 82. Marksans Pharma Business Overview Table 83. Marksans Pharma Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Marksans Pharma Dutasteride Product Portfolio Table 85. Marksans Pharma Recent Development Table 86. Rising Pharmaceuticals Company Information Table 87. Rising Pharmaceuticals Business Overview Table 88. Rising Pharmaceuticals Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Rising Pharmaceuticals Dutasteride Product Portfolio Table 90. Rising Pharmaceuticals Recent Development Table 91. Zydus Company Information Table 92. Zydus Business Overview Table 93. Zydus Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Zydus Dutasteride Product Portfolio Table 95. Zydus Recent Development Table 96. Mylan Company Information Table 97. Mylan Business Overview Table 98. Mylan Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Mylan Dutasteride Product Portfolio Table 100. Mylan Recent Development Table 101. Teva Company Information Table 102. Teva Business Overview Table 103. Teva Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Teva Dutasteride Product Portfolio Table 105. Teva Recent Development Table 106. North America Dutasteride Revenue by Type (2021-2026) & (US$ Million) Table 107. North America Dutasteride Revenue by Type (2027-2032) & (US$ Million) Table 108. North America Dutasteride Sales by Type (2021-2026) & (W Units) Table 109. North America Dutasteride Sales by Type (2027-2032) & (W Units) Table 110. North America Dutasteride Sales Price by Type (2021-2026) & (US$/Unit) Table 111. North America Dutasteride Sales Price by Type (2027-2032) & (US$/Unit) Table 112. North America Dutasteride Revenue by Application (2021-2026) & (US$ Million) Table 113. North America Dutasteride Revenue by Application (2027-2032) & (US$ Million) Table 114. North America Dutasteride Sales by Application (2021-2026) & (W Units) Table 115. North America Dutasteride Sales by Application (2027-2032) & (W Units) Table 116. North America Dutasteride Sales Price by Application (2021-2026) & (US$/Unit) Table 117. North America Dutasteride Sales Price by Application (2027-2032) & (US$/Unit) Table 118. North America Dutasteride Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America Dutasteride Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 120. North America Dutasteride Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 121. North America Dutasteride Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 122. North America Dutasteride Sales by Country (2021-2026) & (W Units) Table 123. North America Dutasteride Sales by Country (2027-2032) & (W Units) Table 124. North America Dutasteride Sales Price by Country (2021-2026) & (US$/Unit) Table 125. North America Dutasteride Sales Price by Country (2027-2032) & (US$/Unit) Table 126. United States Dutasteride Revenue (2021-2032) & (US$ Million) Table 127. Canada Dutasteride Revenue (2021-2032) & (US$ Million) Table 128. Europe Dutasteride Revenue by Type (2021-2026) & (US$ Million) Table 129. Europe Dutasteride Revenue by Type (2027-2032) & (US$ Million) Table 130. Europe Dutasteride Sales by Type (2021-2026) & (W Units) Table 131. Europe Dutasteride Sales by Type (2027-2032) & (W Units) Table 132. Europe Dutasteride Sales Price by Type (2021-2026) & (US$/Unit) Table 133. Europe Dutasteride Sales Price by Type (2027-2032) & (US$/Unit) Table 134. Europe Dutasteride Revenue by Application (2021-2026) & (US$ Million) Table 135. Europe Dutasteride Revenue by Application (2027-2032) & (US$ Million) Table 136. Europe Dutasteride Sales by Application (2021-2026) & (W Units) Table 137. Europe Dutasteride Sales by Application (2027-2032) & (W Units) Table 138. Europe Dutasteride Sales Price by Application (2021-2026) & (US$/Unit) Table 139. Europe Dutasteride Sales Price by Application (2027-2032) & (US$/Unit) Table 140. Europe Dutasteride Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Europe Dutasteride Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. Europe Dutasteride Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. Europe Dutasteride Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 144. Europe Dutasteride Sales by Country (2021-2026) & (W Units) Table 145. Europe Dutasteride Sales by Country (2027-2032) & (W Units) Table 146. Europe Dutasteride Sales Price by Country (2021-2026) & (US$/Unit) Table 147. Europe Dutasteride Sales Price by Country (2027-2032) & (US$/Unit) Table 148. Germany Dutasteride Revenue (2021-2032) & (US$ Million) Table 149. France Dutasteride Revenue (2021-2032) & (US$ Million) Table 150. U.K. Dutasteride Revenue (2021-2032) & (US$ Million) Table 151. Italy Dutasteride Revenue (2021-2032) & (US$ Million) Table 152. Netherlands Dutasteride Revenue (2021-2032) & (US$ Million) Table 153. China Dutasteride Revenue by Type (2021-2026) & (US$ Million) Table 154. China Dutasteride Revenue by Type (2027-2032) & (US$ Million) Table 155. China Dutasteride Sales by Type (2021-2026) & (W Units) Table 156. China Dutasteride Sales by Type (2027-2032) & (W Units) Table 157. China Dutasteride Sales Price by Type (2021-2026) & (US$/Unit) Table 158. China Dutasteride Sales Price by Type (2027-2032) & (US$/Unit) Table 159. China Dutasteride Revenue by Application (2021-2026) & (US$ Million) Table 160. China Dutasteride Revenue by Application (2027-2032) & (US$ Million) Table 161. China Dutasteride Sales by Application (2021-2026) & (W Units) Table 162. China Dutasteride Sales by Application (2027-2032) & (W Units) Table 163. China Dutasteride Sales Price by Application (2021-2026) & (US$/Unit) Table 164. China Dutasteride Sales Price by Application (2027-2032) & (US$/Unit) Table 165. Asia Dutasteride Revenue by Type (2021-2026) & (US$ Million) Table 166. Asia Dutasteride Revenue by Type (2027-2032) & (US$ Million) Table 167. Asia Dutasteride Sales by Type (2021-2026) & (W Units) Table 168. Asia Dutasteride Sales by Type (2027-2032) & (W Units) Table 169. Asia Dutasteride Sales Price by Type (2021-2026) & (US$/Unit) Table 170. Asia Dutasteride Sales Price by Type (2027-2032) & (US$/Unit) Table 171. Asia Dutasteride Revenue by Application (2021-2026) & (US$ Million) Table 172. Asia Dutasteride Revenue by Application (2027-2032) & (US$ Million) Table 173. Asia Dutasteride Sales by Application (2021-2026) & (W Units) Table 174. Asia Dutasteride Sales by Application (2027-2032) & (W Units) Table 175. Asia Dutasteride Sales Price by Application (2021-2026) & (US$/Unit) Table 176. Asia Dutasteride Sales Price by Application (2027-2032) & (US$/Unit) Table 177. Asia Dutasteride Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. Asia Dutasteride Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. Asia Dutasteride Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. Asia Dutasteride Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 181. Asia Dutasteride Sales by Country (2021-2026) & (W Units) Table 182. Asia Dutasteride Sales by Country (2027-2032) & (W Units) Table 183. Asia Dutasteride Sales Price by Country (2021-2026) & (US$/Unit) Table 184. Asia Dutasteride Sales Price by Country (2027-2032) & (US$/Unit) Table 185. Japan Dutasteride Revenue (2021-2032) & (US$ Million) Table 186. South Korea Dutasteride Revenue (2021-2032) & (US$ Million) Table 187. India Dutasteride Revenue (2021-2032) & (US$ Million) Table 188. Australia Dutasteride Revenue (2021-2032) & (US$ Million) Table 189. China Taiwan Dutasteride Revenue (2021-2032) & (US$ Million) Table 190. Southeast Asia Dutasteride Revenue (2021-2032) & (US$ Million) Table 191. SAMEA Dutasteride Revenue by Type (2021-2026) & (US$ Million) Table 192. SAMEA Dutasteride Revenue by Type (2027-2032) & (US$ Million) Table 193. SAMEA Dutasteride Sales by Type (2021-2026) & (W Units) Table 194. SAMEA Dutasteride Sales by Type (2027-2032) & (W Units) Table 195. SAMEA Dutasteride Sales Price by Type (2021-2026) & (US$/Unit) Table 196. SAMEA Dutasteride Sales Price by Type (2027-2032) & (US$/Unit) Table 197. SAMEA Dutasteride Revenue by Application (2021-2026) & (US$ Million) Table 198. SAMEA Dutasteride Revenue by Application (2027-2032) & (US$ Million) Table 199. SAMEA Dutasteride Sales by Application (2021-2026) & (W Units) Table 200. SAMEA Dutasteride Sales by Application (2027-2032) & (W Units) Table 201. SAMEA Dutasteride Sales Price by Application (2021-2026) & (US$/Unit) Table 202. SAMEA Dutasteride Sales Price by Application (2027-2032) & (US$/Unit) Table 203. SAMEA Dutasteride Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 204. SAMEA Dutasteride Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 205. SAMEA Dutasteride Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 206. SAMEA Dutasteride Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 207. SAMEA Dutasteride Sales by Country (2021-2026) & (W Units) Table 208. SAMEA Dutasteride Sales by Country (2027-2032) & (W Units) Table 209. SAMEA Dutasteride Sales Price by Country (2021-2026) & (US$/Unit) Table 210. SAMEA Dutasteride Sales Price by Country (2027-2032) & (US$/Unit) Table 211. Brazil Dutasteride Revenue (2021-2032) & (US$ Million) Table 212. Argentina Dutasteride Revenue (2021-2032) & (US$ Million) Table 213. Chile Dutasteride Revenue (2021-2032) & (US$ Million) Table 214. Colombia Dutasteride Revenue (2021-2032) & (US$ Million) Table 215. Peru Dutasteride Revenue (2021-2032) & (US$ Million) Table 216. Saudi Arabia Dutasteride Revenue (2021-2032) & (US$ Million) Table 217. Israel Dutasteride Revenue (2021-2032) & (US$ Million) Table 218. UAE Dutasteride Revenue (2021-2032) & (US$ Million) Table 219. Turkey Dutasteride Revenue (2021-2032) & (US$ Million) Table 220. Iran Dutasteride Revenue (2021-2032) & (US$ Million) Table 221. Egypt Dutasteride Revenue (2021-2032) & (US$ Million) Table 222. Key Raw Materials Table 223. Raw Materials Key Suppliers Table 224. Dutasteride Distributors List Table 225. Dutasteride Customers List Table 226. Research Programs/Design for This Report Table 227. Authors List of This Report Table 228. Secondary Sources Table 229. Primary Sources List of Figures Figure 1. Dutasteride Image Figure 2. Global Dutasteride Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dutasteride Market Size Share 2021 VS 2025 VS 2032 Figure 4. Type I Image Figure 5. Type II Image Figure 6. Global Dutasteride Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Dutasteride Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Drug Store Image Figure 10. Global Dutasteride Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Dutasteride Revenue (2021-2032) & (US$ Million) Figure 12. Global Dutasteride Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Dutasteride Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Dutasteride Revenue Market Share by Region (2021-2032) Figure 15. Global Dutasteride Sales (2021-2032) & (W Units) Figure 16. Global Dutasteride Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 17. Global Dutasteride Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Dutasteride Sales YoY (2021-2032) & (W Units) Figure 19. Europe Dutasteride Sales YoY (2021-2032) & (W Units) Figure 20. China Dutasteride Sales YoY (2021-2032) & (W Units) Figure 21. Asia (Excluding China) Dutasteride Sales YoY (2021-2032) & (W Units) Figure 22. South America, Middle East and Africa Dutasteride Sales YoY (2021-2032) & (W Units) Figure 23. Global Dutasteride Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Dutasteride Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Dutasteride Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Dutasteride Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Dutasteride Revenue Market Share by Type (2021-2032) Figure 29. Global Dutasteride Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 30. Global Dutasteride Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Dutasteride Sales Market Share by Type (2021-2032) Figure 32. Global Dutasteride Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Dutasteride Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Dutasteride Revenue Market Share by Application (2021-2032) Figure 35. Global Dutasteride Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 36. Global Dutasteride Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Dutasteride Sales Market Share by Application (2021-2032) Figure 38. North America Dutasteride Revenue Share by Type (2021-2032) Figure 39. North America Dutasteride Sales Share by Type (2021-2032) Figure 40. North America Dutasteride Revenue Share by Application (2021-2032) Figure 41. North America Dutasteride Sales Share by Application (2021-2032) Figure 42. North America Dutasteride Revenue Share by Country (2021-2032) Figure 43. North America Dutasteride Sales Share by Country (2021-2032) Figure 44. Europe Dutasteride Revenue Share by Type (2021-2032) Figure 45. Europe Dutasteride Sales Share by Type (2021-2032) Figure 46. Europe Dutasteride Revenue Share by Application (2021-2032) Figure 47. Europe Dutasteride Sales Share by Application (2021-2032) Figure 48. Europe Dutasteride Revenue Share by Country (2021-2032) Figure 49. Europe Dutasteride Sales Share by Country (2021-2032) Figure 50. China Dutasteride Revenue Share by Type (2021-2032) Figure 51. China Dutasteride Sales Share by Type (2021-2032) Figure 52. China Dutasteride Revenue Share by Application (2021-2032) Figure 53. China Dutasteride Sales Share by Application (2021-2032) Figure 54. Asia Dutasteride Revenue Share by Type (2021-2032) Figure 55. Asia Dutasteride Sales Share by Type (2021-2032) Figure 56. Asia Dutasteride Revenue Share by Application (2021-2032) Figure 57. Asia Dutasteride Sales Share by Application (2021-2032) Figure 58. Asia Dutasteride Revenue Share by Country (2021-2032) Figure 59. Asia Dutasteride Sales Share by Country (2021-2032) Figure 60. SAMEA Dutasteride Revenue Share by Type (2021-2032) Figure 61. SAMEA Dutasteride Sales Share by Type (2021-2032) Figure 62. SAMEA Dutasteride Revenue Share by Application (2021-2032) Figure 63. SAMEA Dutasteride Sales Share by Application (2021-2032) Figure 64. SAMEA Dutasteride Revenue Share by Country (2021-2032) Figure 65. SAMEA Dutasteride Sales Share by Country (2021-2032) Figure 66. Dutasteride Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Dutasteride Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Type I
  • Type II
Applications
  • Hospital
  • Drug Store
Companies covered
  • GSK
  • Amneal Pharma
  • Apotex
  • Bionpharma
  • Breckenridge Pharmaceutical
  • Marksans Pharma
  • Rising Pharmaceuticals
  • Zydus
  • Mylan
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dutasteride Market by Type
  3. 1.2.1 Global Dutasteride Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Type I
  5. 1.2.3 Type II
  6. 1.3 Dutasteride Market by Application
  7. 1.3.1 Global Dutasteride Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Drug Store
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Dutasteride Market Dynamics
  1. 2.1 Dutasteride Industry Trends
  2. 2.2 Dutasteride Industry Drivers
  3. 2.3 Dutasteride Industry Opportunities and Challenges
  4. 2.4 Dutasteride Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dutasteride Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dutasteride Revenue by Region
  3. 3.2.1 Global Dutasteride Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dutasteride Revenue by Region (2021-2026)
  5. 3.2.3 Global Dutasteride Revenue by Region (2027-2032)
  6. 3.2.4 Global Dutasteride Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dutasteride Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dutasteride Sales by Region
  9. 3.4.1 Global Dutasteride Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dutasteride Sales by Region (2021-2026)
  11. 3.4.3 Global Dutasteride Sales by Region (2027-2032)
  12. 3.4.4 Global Dutasteride Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dutasteride Revenue by Manufacturers
  2. 4.1.1 Global Dutasteride Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dutasteride Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dutasteride Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dutasteride Sales by Manufacturers
  6. 4.2.1 Global Dutasteride Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dutasteride Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dutasteride Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dutasteride Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dutasteride Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dutasteride Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dutasteride Manufacturers, Product Type & Application
  13. 4.7 Global Dutasteride Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dutasteride Market CR5 and HHI
  16. 4.8.2 2025 Dutasteride Tier 1, Tier 2, and Tier 3
5 Dutasteride Market by Type
  1. 5.1 Global Dutasteride Revenue by Type
  2. 5.1.1 Global Dutasteride Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dutasteride Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dutasteride Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dutasteride Sales by Type
  6. 5.2.1 Global Dutasteride Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dutasteride Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Dutasteride Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dutasteride Price by Type
6 Dutasteride Market by Application
  1. 6.1 Global Dutasteride Revenue by Application
  2. 6.1.1 Global Dutasteride Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dutasteride Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dutasteride Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dutasteride Sales by Application
  6. 6.2.1 Global Dutasteride Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dutasteride Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Dutasteride Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dutasteride Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Dutasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Dutasteride Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 Amneal Pharma
  8. 7.2.1 Amneal Pharma Company Information
  9. 7.2.2 Amneal Pharma Business Overview
  10. 7.2.3 Amneal Pharma Dutasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Amneal Pharma Dutasteride Product Portfolio
  12. 7.2.5 Amneal Pharma Recent Developments
  13. 7.3 Apotex
  14. 7.3.1 Apotex Company Information
  15. 7.3.2 Apotex Business Overview
  16. 7.3.3 Apotex Dutasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Apotex Dutasteride Product Portfolio
  18. 7.3.5 Apotex Recent Developments
  19. 7.4 Bionpharma
  20. 7.4.1 Bionpharma Company Information
  21. 7.4.2 Bionpharma Business Overview
  22. 7.4.3 Bionpharma Dutasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bionpharma Dutasteride Product Portfolio
  24. 7.4.5 Bionpharma Recent Developments
  25. 7.5 Breckenridge Pharmaceutical
  26. 7.5.1 Breckenridge Pharmaceutical Company Information
  27. 7.5.2 Breckenridge Pharmaceutical Business Overview
  28. 7.5.3 Breckenridge Pharmaceutical Dutasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Breckenridge Pharmaceutical Dutasteride Product Portfolio
  30. 7.5.5 Breckenridge Pharmaceutical Recent Developments
  31. 7.6 Marksans Pharma
  32. 7.6.1 Marksans Pharma Company Information
  33. 7.6.2 Marksans Pharma Business Overview
  34. 7.6.3 Marksans Pharma Dutasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Marksans Pharma Dutasteride Product Portfolio
  36. 7.6.5 Marksans Pharma Recent Developments
  37. 7.7 Rising Pharmaceuticals
  38. 7.7.1 Rising Pharmaceuticals Company Information
  39. 7.7.2 Rising Pharmaceuticals Business Overview
  40. 7.7.3 Rising Pharmaceuticals Dutasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Rising Pharmaceuticals Dutasteride Product Portfolio
  42. 7.7.5 Rising Pharmaceuticals Recent Developments
  43. 7.8 Zydus
  44. 7.8.1 Zydus Company Information
  45. 7.8.2 Zydus Business Overview
  46. 7.8.3 Zydus Dutasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Zydus Dutasteride Product Portfolio
  48. 7.8.5 Zydus Recent Developments
  49. 7.9 Mylan
  50. 7.9.1 Mylan Company Information
  51. 7.9.2 Mylan Business Overview
  52. 7.9.3 Mylan Dutasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Mylan Dutasteride Product Portfolio
  54. 7.9.5 Mylan Recent Developments
  55. 7.10 Teva
  56. 7.10.1 Teva Company Information
  57. 7.10.2 Teva Business Overview
  58. 7.10.3 Teva Dutasteride Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Teva Dutasteride Product Portfolio
  60. 7.10.5 Teva Recent Developments
8 North America
  1. 8.1 North America Dutasteride Market Size by Type
  2. 8.1.1 North America Dutasteride Revenue by Type (2021-2032)
  3. 8.1.2 North America Dutasteride Sales by Type (2021-2032)
  4. 8.1.3 North America Dutasteride Price by Type (2021-2032)
  5. 8.2 North America Dutasteride Market Size by Application
  6. 8.2.1 North America Dutasteride Revenue by Application (2021-2032)
  7. 8.2.2 North America Dutasteride Sales by Application (2021-2032)
  8. 8.2.3 North America Dutasteride Price by Application (2021-2032)
  9. 8.3 North America Dutasteride Market Size by Country
  10. 8.3.1 North America Dutasteride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dutasteride Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dutasteride Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Dutasteride Market Size by Type
  2. 9.1.1 Europe Dutasteride Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dutasteride Sales by Type (2021-2032)
  4. 9.1.3 Europe Dutasteride Price by Type (2021-2032)
  5. 9.2 Europe Dutasteride Market Size by Application
  6. 9.2.1 Europe Dutasteride Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dutasteride Sales by Application (2021-2032)
  8. 9.2.3 Europe Dutasteride Price by Application (2021-2032)
  9. 9.3 Europe Dutasteride Market Size by Country
  10. 9.3.1 Europe Dutasteride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dutasteride Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dutasteride Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Dutasteride Market Size by Type
  2. 10.1.1 China Dutasteride Revenue by Type (2021-2032)
  3. 10.1.2 China Dutasteride Sales by Type (2021-2032)
  4. 10.1.3 China Dutasteride Price by Type (2021-2032)
  5. 10.2 China Dutasteride Market Size by Application
  6. 10.2.1 China Dutasteride Revenue by Application (2021-2032)
  7. 10.2.2 China Dutasteride Sales by Application (2021-2032)
  8. 10.2.3 China Dutasteride Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dutasteride Market Size by Type
  2. 11.1.1 Asia Dutasteride Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dutasteride Sales by Type (2021-2032)
  4. 11.1.3 Asia Dutasteride Price by Type (2021-2032)
  5. 11.2 Asia Dutasteride Market Size by Application
  6. 11.2.1 Asia Dutasteride Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dutasteride Sales by Application (2021-2032)
  8. 11.2.3 Asia Dutasteride Price by Application (2021-2032)
  9. 11.3 Asia Dutasteride Market Size by Country
  10. 11.3.1 Asia Dutasteride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dutasteride Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dutasteride Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dutasteride Market Size by Type
  2. 12.1.1 SAMEA Dutasteride Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dutasteride Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dutasteride Price by Type (2021-2032)
  5. 12.2 SAMEA Dutasteride Market Size by Application
  6. 12.2.1 SAMEA Dutasteride Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dutasteride Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dutasteride Price by Application (2021-2032)
  9. 12.3 SAMEA Dutasteride Market Size by Country
  10. 12.3.1 SAMEA Dutasteride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dutasteride Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dutasteride Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dutasteride Value Chain Analysis
  2. 13.1.1 Dutasteride Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dutasteride Production Mode & Process
  6. 13.2 Dutasteride Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dutasteride Distributors
  9. 13.2.3 Dutasteride Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst